Endpoint Health is a California-based biotechnology company that develops and commercializes therapeutics for the treatment of immune-mediated acute and chronic diseases.
$25M
Feb 23, 2022
-
Bloodbuy is a cloud-based digital healthcare platform that allows users to search for blood products and healthcare centers.
-
Jul 22, 2020
-
Shanghai RAAS is a China-based company that manufactures and markets blood products such as immunoglobulins and coagulation factors for the pharmaceutical sector.
$1.9B
Mar 07, 2019
-
GigaGen is a biotechnology company that develops and commercializes single-cell technology-based antibody drugs to treat infectious diseases.
$36.1M
Jul 02, 2017
-
Singulex develops and provides single molecule counting technology for clinical diagnostics and scientific discovery.
$50M
May 16, 2016
-
Frequently Asked Questions about Grifols
What is Grifols investing in?
Grifols has invested in 6 companies including Endpoint Health, Bloodbuy and Shanghai RAAS
What company did Grifols invest in?
Grifols invested in a total 6 companies including Endpoint Health, Bloodbuy and Shanghai RAAS
What are the top 5 investments by Grifols?
The top companies in which Grifols invested are Endpoint Health, Bloodbuy, Shanghai RAAS, GigaGen and Singulex, Inc.
